Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shelley Crary

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPeds Pediatrics, College of Medicine
DivisionPeds Hematology
Address ACH Sturgis Building
800 Marshall Street
Mail Slot # 512-10
Little Rock AR 72202
Phone501-364-4150
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    GR034699     (CRARY, SHELLEY E)Sep 30, 2022 - Sep 29, 2023
    UAMS ACHRI Flow Through
    Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting
    Role: Principal Investigator

    GR034186     (CRARY, SHELLEY E)Jun 1, 2022 - May 31, 2023
    University of Texas - Pass Through: UAMS ACHRI Flow Through
    GR034186-Crary-HRSA Great Plains Regional Hemophilia Network-UT
    Role: Principal Investigator

    ACRI #037112     (CRARY, SHELLEY E)Oct 1, 2017 - Apr 30, 2020
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator

    ACRI#037112     (CRARY, SHELLEY E)Oct 1, 2017 - Apr 30, 2020
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator

    ACHRI # 036192     (CRARY, SHELLEY E)Oct 25, 2013 - Oct 31, 2015
    UAMS College of Medicine
    CUMG
    Role: Principal Investigator

    ACHRI#036192     (CRARY, SHELLEY E)Oct 25, 2013 - Oct 31, 2015
    UAMS College of Medicine
    CUMG
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse additional bibliographic sources
    The links below are provided by the researcher to provide access to external online bibliographies that they keep independently from the Profiles System.
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Appell LE, Mack JM, Farrar JE, Roper SN, Savage MR, Pandey S, Crary SE. Acquired Hemophilia: A Rare Complication of Pediatric Idiopathic Multicentric Castleman Disease. Pediatrics. 2024 Apr 01; 153(4). PMID: 38511235.
      View in: PubMed
    2. Tran AD, Waller E, Mack JM, Crary SE, Citla-Sridhar D. Mental health in persons with von Willebrand disease in the United States - a large national database study. J Thromb Haemost. 2024 Mar 05. PMID: 38453024.
      View in: PubMed
    3. Borst AJ, Eng W, Griffin M, Ricci KW, Engel E, Adams DM, Dayneka J, Cohen-Cutler SJ, Andreoli SM, Wu MD, Wheeler AP, Heym KM, Crary SE, Nakano TA, Schulte RR, Setty BA, McLean TW, Pahl KS, Intzes S, Pateva I, Teitelbaum M, Zong Z, Li Y, Jeng MR. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study. Pediatr Blood Cancer. 2024 Mar; 71(3):e30779. PMID: 38073018.
      View in: PubMed
    4. Borst AJ, Hammill AM, Crary SE, McLean TW, Felton T, Blatt J. Barriers to Genetic Testing in Vascular Malformations. JAMA Netw Open. 2023 05 01; 6(5):e2314829. PMID: 37219903.
      View in: PubMed
    5. Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, O'Connell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE. Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B. N Engl J Med. 2023 02 23; 388(8):706-718. PMID: 36812434.
      View in: PubMed
    6. Mack JM, Crary SE. How we approach coagulopathy with vascular anomalies. Pediatr Blood Cancer. 2022 08; 69 Suppl 3:e29353. PMID: 36070211.
      View in: PubMed
    7. Mack JM, Peterson EC, Crary SE, Moran JH, Neville K, Pierce CD, Richter GT. Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations. Pediatr Blood Cancer. 2022 08; 69(8):e29733. PMID: 35484878.
      View in: PubMed
    8. Mack JM, Frankowski S, Verkamp B, Crary SE, Spray B, Crawley L, Saccente S, Neville KA. Pupil Size and Reactivity in Pediatric Patients With Sickle Cell Disease. J Pediatr Hematol Oncol. 2023 01 01; 45(1):e44-e47. PMID: 34966094.
      View in: PubMed
    9. Liles DK, Shah NR, Scullin B, Gordeuk VR, Smith WR, Kanter J, Achebe MM, Boccia R, Crary SE, Kraft WK, Archer N, Cataldo V, Hardesty BM, Idowu M, Desai PC, Ikeda A, Puthenveetil G, Hassell KL, Sarnaik S, Kutlar A. Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study. Br J Haematol. 2021 11; 195(4):e150-e153. PMID: 34611900.
      View in: PubMed
    10. Mack JM, Pierce CD, Richter GT, Spray BJ, Nicholas R, Lewis PS, Becton D, Crary SE. Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography. Pediatr Blood Cancer. 2021 02; 68(2):e28824. PMID: 33211399.
      View in: PubMed
    11. Matehuala S, Pasala S, Goudie A, Fiser R, Weiss S, Irby K, Crary S, Wang A, Sanders R. Association Between Elevated RBC Distribution Width and Multiple Organ Dysfunction in Pediatric Critical Illness. Pediatr Crit Care Med. 2020 09; 21(9):e740-e746. PMID: 32701753.
      View in: PubMed
    12. Mack JM, Verkamp B, Richter GT, Nicholas R, Stewart K, Crary SE. Effect of sirolimus on coagulopathy of slow-flow vascular malformations. Pediatr Blood Cancer. 2019 10; 66(10):e27896. PMID: 31250546.
      View in: PubMed
    13. Blatt J, Finger M, Price V, Crary SE, Pandya A, Adams DM. Cancer Risk in Klippel-Trenaunay Syndrome. Lymphat Res Biol. 2019 12; 17(6):630-636. PMID: 31045469.
      View in: PubMed
    14. Grace RF, Shimano KA, Bhat R, Neunert C, Bussel JB, Klaassen RJ, Lambert MP, Rothman JA, Breakey VR, Hege K, Bennett CM, Rose MJ, Haley KM, Buchanan GR, Geddis A, Lorenzana A, Jeng M, Pastore YD, Crary SE, Neier M, Neufeld EJ, Neu N, Forbes PW, Despotovic JM. Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. Am J Hematol. 2019 07; 94(7):741-750. PMID: 30945320.
      View in: PubMed
    15. Samanta D, Ramakrishnaiah R, Crary SE, Sukumaran S, Burrow TA. Multiple Autoimmune Disorders in Aicardi-Gouti?res Syndrome. Pediatr Neurol. 2019 07; 96:37-39. PMID: 30898416.
      View in: PubMed
    16. Jeffreys SM, Levy RA, Crary SE. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder. J Pediatr Hematol Oncol. 2018 07; 40(5):e305-e308. PMID: 28991130.
      View in: PubMed
    17. Grace RF, Despotovic JM, Bennett CM, Bussel JB, Neier M, Neunert C, Crary SE, Pastore YD, Klaassen RJ, Rothman JA, Hege K, Breakey VR, Rose MJ, Shimano KA, Buchanan GR, Geddis A, Haley KM, Lorenzana A, Thompson A, Jeng M, Neufeld EJ, Brown T, Forbes PW, Lambert MP. Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. Am J Hematol. 2018 07; 93(7):882-888. PMID: 29659042.
      View in: PubMed
    18. Mack JM, Richter GT, Crary SE. Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series. Lymphat Res Biol. 2018 06; 16(3):278-281. PMID: 29583078.
      View in: PubMed
    19. Mack JM, Richter GT, Becton D, Salem O, Hill SEM, Crary SE. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations. Pediatr Blood Cancer. 2018 06; 65(6):e27008. PMID: 29431255.
      View in: PubMed
    20. Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Jason Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter SD, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML, Rice HE. Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia. J Pediatr Surg. 2016 Jan; 51(1):122-7. PMID: 26613837.
      View in: PubMed
    21. Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA. Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. J Clin Pharmacol. 2016 Mar; 56(3):298-306. PMID: 26201504.
      View in: PubMed
    22. Rice HE, Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter S, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML. Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry. Am J Hematol. 2015 Mar; 90(3):187-92. PMID: 25382665.
      View in: PubMed
    23. Plummer ES, Crary SE, Buchanan GR. Prominent forehead hematomas ("goose-eggs") as an initial manifestation of hemophilia. J Pediatr. 2013 Dec; 163(6):1781-3. PMID: 23968747.
      View in: PubMed
    24. Roy SM, Buchanan GR, Crary SE. Splenectomy in children with "mild" hereditary spherocytosis. J Pediatr Hematol Oncol. 2013 Aug; 35(6):430-3. PMID: 23823113.
      View in: PubMed
    25. Plummer ES, Crary SE, McCavit TL, Buchanan GR. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. Pediatr Blood Cancer. 2013 Nov; 60(11):1747-52. PMID: 23832487.
      View in: PubMed
    26. Mathew, S., Buchanan, GR, Crary, S. Medical and Quality of Life Indications for Splenectomy in Children with Hereditary Spherocytosis. J Ped Hem Onc. 2013.
    27. Crary, SE, Buchanan, GB. Pediatric and Adolescent Hematology. Iron Deficiency: When and Why Oral Iron May Not Be Enough. 2013.
    28. Plummer, E., Crary, SE, Buchanan, GR. Intravenous Low Molecular Weight Iron Dextran (LMWID) in the Treatment of Children with Iron Deficiency Anemia. American Society of Pediatric Hematology/Oncology Annual Meeting. 2012.
    29. Rice HE, Crary SE, Langer JC, Kemper AR. Comparative effectiveness of different types of splenectomy for children with congenital hemolytic anemias. J Pediatr. 2012 Apr; 160(4):684-689.e13. PMID: 22050869.
      View in: PubMed
    30. Crary SE, Ramaciotti C, Buchanan GR. Prevalence of pulmonary hypertension in hereditary spherocytosis. Am J Hematol. 2011 Dec; 86(12):E73-6. PMID: 21953840.
      View in: PubMed
    31. Chen KS, Neunert CE, Crary SE, Buchanan GR. Hemolytic non-uremic syndrome. Pediatr Blood Cancer. 2012 Jul 15; 59(1):167-9. PMID: 21809436.
      View in: PubMed
    32. Plummer, E., Crary, SE, Buchanan, GR. Intravenous Low Molecular Weight Iron Dextran (LMWID) in the Treatment of Children with Iron Deficiency Anemia. Blood. 2011; 3184.
    33. Crary, SE. Rudolph's Pediatrics. The Spleen and Lymph Nodes. 2011; 440.
    34. Crary SE, Hall K, Buchanan GR. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatr Blood Cancer. 2011 Apr; 56(4):615-9. PMID: 21298748.
      View in: PubMed
    35. Crary SE, Troendle S, Ahmad N, Buchanan GR. Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis. Pediatr Blood Cancer. 2010 Oct; 55(4):684-9. PMID: 20589636.
      View in: PubMed
    36. Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood. 2009 Oct 01; 114(14):2861-8. PMID: 19636061.
      View in: PubMed
    37. Purcell PL, Crary SE, Adix LM, Alder AC, Buchanan GR. Postsplenectomy vascular complications: Feasibility of studying patients with splenectomy following trauma. Am J Hematol. 2009 May; 84(5):316-7. PMID: 19338046.
      View in: PubMed
    38. Crary, SE, Bolton-Maggs, P. Hereditary Spherocytosis. 2009.
    39. Purcell PL, Crary, SE, Adix, L, Alder, A, Buchanan, GR. Post-Splenectomy Complications: Feasibility of Studying Patients with Splenectomy following Trauma. Am J Hematol. 2009; 84:316-317.
    40. Crary, SE, Buchanan, GR. Vascular Complications Following Splenectomy for Hematologic Disorders. Blood. 2009; 114:2861-2868.
    41. Crary SE, Van Orden H, Journeycake JM. Experience with intravenous enoxaparin in critically ill infants and children. Pediatr Crit Care Med. 2008 Nov; 9(6):647-9. PMID: 18838932.
      View in: PubMed
    42. Troendle SB, Adix L, Crary SE, Buchanan GR. Laboratory markers of thrombosis risk in children with hereditary spherocytosis. Pediatr Blood Cancer. 2007 Nov; 49(6):781-5. PMID: 17854065.
      View in: PubMed
    43. Crary SE, Buchanan GR, Drake CE, Journeycake JM. Venous thrombosis and thromboembolism in children with osteomyelitis. J Pediatr. 2006 Oct; 149(4):537-41. PMID: 17011328.
      View in: PubMed
    Crary's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description